Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


pSivida makes board appointments

This article was originally published in Scrip

Executive Summary

The US drug delivery company pSivida has appointed Peter Savas and Paul Hopper as non-executive directors. Mr Savas is chairman and chief executive officer of Alseres Pharmaceuticals, a company developing biopharmaceutical products for the diagnosis of degenerative neurological diseases and the treatment of acute spinal cord injury, while Mr Hopper is the founder and lead director of Polynoma and also a director of Somnomed, which manufactures and markets a dental device for sleep disorders.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts